Alginate plasma expander maintains perfusion and plasma viscosity during extreme hemodilution
- 1 April 2005
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 288 (4) , H1708-H1716
- https://doi.org/10.1152/ajpheart.00911.2004
Abstract
Extreme hemodilution was performed in the hamster chamber window model using 6% Dextran 70, lowering systemic hematocrit by 60%. Animals were subsequently divided into three groups and hemodiluted to a hematocrit of 11% using 6% Dextran 70, 6% Dextran 500, and a 4% Dextran 70 + 0.7% alginate solution ( n = 6 each group). Final plasma viscosities were 1.4 ± 0.2, 2.2 ± 0.1, and 2.7 ± 0.2 cp, respectively, ( P < 0.05, high viscosity vs. low viscosity). Blood viscosities were 2.1 ± 0.2, 2.9 ± 0.4, and 3.9 ± 0.3 cp, respectively. The lowest blood and plasma viscosity group had a significantly lower functional capillary density, 37 ± 16%, whereas the two high-viscosity solutions were 71 ± 15% and 76 ± 12% ( P < 0.05, high viscosity vs. low viscosity), respectively. Arteriolar and venular flow in the Dextran 500 and alginate groups was higher than baseline (i.e., normal nontreated animals), whereas the low-viscosity group showed a reduction in flow. These microvascular changes were paralleled by changes in base excess, which was negative for the Dextran 70 group and positive for the other groups. However, tissue Po2 was uniformly low for all groups (average of 1.4 mmHg). Calculation of tissue oxygen consumption in the window chamber based on the microvascular data, flow, and intravascular Po2 showed that only the alginate + Dextran 70 solution-exchanged animals returned to baseline oxygen consumption, whereas the other groups were lower than baseline ( P < 0.05). These results show that hemodilution performed with high-viscosity plasma expanders yields systemic arterial pressures and functional capillary densities that are significantly higher ( P < 0.05) than those obtained with 6% Dextran 70, a fluid whose viscosity is similar to that of plasma. A condition for obtaining these results is that the oncotic pressure of the plasma expander be titrated to near normal, so that autotransfusion of fluid from the tissue into the vascular compartment does not reduce the effects of increasing plasma viscosity and increased shear stress on the microvascular wall.Keywords
This publication has 34 references indexed in Scilit:
- HYPEROSMOTIC-HYPERONCOTIC VERSUS HYPEROSMOTIC-HYPERVISCOUS: SMALL VOLUME RESUSCITATION IN HEMORRHAGIC SHOCKShock, 2004
- Microvascular Po2during extreme hemodilution with hemoglobin site specifically PEGylated at Cys-93(β) in hamster window chamberAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Oxygen distribution in microcirculation after arginine vasopressin-induced arteriolar vasoconstrictionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Microvascular pressure and functional capillary density in extreme hemodilution with low- and high-viscosity dextran and a low-viscosity Hb-based O2 carrierAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Oxygen delivery and consumption in the microcirculation after extreme hemodilution with perfluorocarbonsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Endothelium-dependent arterial wall tone elasticity modulated by blood viscosityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2002
- Mannuronan C-5-Epimerases and Their Application for in Vitro and in Vivo Design of New Alginates Useful in BiotechnologyMetabolic Engineering, 1999
- Flow Effects on Prostacyclin Production by Cultured Human Endothelial CellsScience, 1985
- Blood flow and in vivo apparent viscosity in working and non-working skeletal muscle of the dog after high and low molecular weight dextran.Circulation Research, 1981
- Technical report—a new chamber technique for microvascular studies in unanesthetized hamstersZeitschrift für Die Gesamte Experimentelle Medizin, 1980